TrialJournal of neurovirology2026

Clinical and behavioral predictors of HIV-associated neurocognitive disorder among people with HIV who use substances: a secondary analysis of the HOPE trial.

Gloria Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.